Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Co-Diagnostics ( (CODX) ) has shared an update.
On January 7, 2026, Co-Diagnostics received notice from Nasdaq that its common stock would be delisted from the Nasdaq Capital Market for continued non-compliance with the minimum $1.00 bid price requirement, after failing to maintain that level for the required 10 consecutive trading days by the end of its second 180-day grace period on January 5, 2026. Trading in the company’s securities is set to be suspended from Nasdaq at the open on January 14, 2026, with the shares expected to move to the Pink Limited Information tier of the OTC Market under the current “CODX” symbol; although the stock has traded at or above $1.00 since January 2, 2026 following a reverse split, Co-Diagnostics is seeking a favorable compliance determination from Nasdaq staff if it can maintain the required bid price through January 15, 2026, but there is no guarantee it will avoid or reverse the delisting, leaving investors facing heightened trading and liquidity risks.
The most recent analyst rating on (CODX) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Co-Diagnostics stock, see the CODX Stock Forecast page.
Spark’s Take on CODX Stock
According to Spark, TipRanks’ AI Analyst, CODX is a Neutral.
CODX scores low primarily due to deteriorated profitability and persistent cash burn, despite a low-leverage balance sheet. Technicals also remain weak with the stock below key moving averages and negative MACD. The earnings call adds some support through clearer strategic initiatives and improved expense control, but current revenue levels and ongoing losses materially constrain the outlook.
To see Spark’s full report on CODX stock, click here.
More about Co-Diagnostics
Co-Diagnostics, Inc. operates in the diagnostics and molecular testing industry, with its common stock historically listed on the Nasdaq Capital Market under the ticker symbol “CODX.” The company’s shares recently underwent a 1-for-30 reverse stock split, effective January 2, 2026, aimed at lifting its per-share trading price and addressing compliance with Nasdaq’s minimum bid price requirements.
Average Trading Volume: 713,666
Technical Sentiment Signal: Sell
Current Market Cap: $12.97M
See more data about CODX stock on TipRanks’ Stock Analysis page.